Apollo Global Management's (APO) Novolex has agreed to buy Pactiv Evergreen (PTVE) for $18 per share in an all-cash deal valued at $6.70 billion, the companies said Monday.
Following deal closure expected in mid-2025, Pactiv Evergreen shares will no longer be listed on the Nasdaq and the combined company will be led by Novolex CEO and Chairman Stan Bikulege, the companies said.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.